Our clients include world's top universities and pharmaceutical organizations
Telix Pharmaceuticals
Tuesday, April 1, 2025
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
Phathom Pharmaceuticals
Tuesday, April 1, 2025
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Genmab
Tuesday, April 1, 2025
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Valneva SE
Tuesday, April 1, 2025
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
Nature
Monday, March 31, 2025
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
Nature
Monday, March 31, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
Aptose Biosciences
Tuesday, April 1, 2025
Aptose Common Shares to Delist from Nasdaq as of April 2, 2025
MAIA Biotechnology
Tuesday, April 1, 2025
MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders
Phathom Pharmaceuticals
Tuesday, April 1, 2025
Phathom Pharmaceuticals Announces Leadership Succession
Merus
Tuesday, April 1, 2025
Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Nature
Sunday, March 30, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease
New England Journal of Medicine
Sunday, March 30, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
New England Journal of Medicine
Sunday, March 30, 2025
Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
Recursion Pharmaceuticals
Tuesday, April 1, 2025
Recursion to Participate in Upcoming Investor Conference
electroCore
Tuesday, April 1, 2025
electroCore to Participate at the Needham Virtual Healthcare Conference
Precision BioSciences
Tuesday, April 1, 2025
Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
Tonix Pharmaceuticals
Tuesday, April 1, 2025
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
Lancet
Saturday, March 29, 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial
Lancet
Saturday, March 29, 2025
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Lancet
Saturday, March 29, 2025
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial
Nature
Saturday, March 29, 2025
Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
CRISPR Therapeutics
Tuesday, April 1, 2025
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
Merck
Tuesday, April 1, 2025
Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24
Capricor Therapeutics
Tuesday, April 1, 2025
Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
Abeona Therapeutics
Tuesday, April 1, 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nature
Saturday, March 29, 2025
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial
New England Journal of Medicine
Saturday, March 29, 2025
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
New England Journal of Medicine
Saturday, March 29, 2025
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
New England Journal of Medicine
Saturday, March 29, 2025
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
14 14
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.